Pain Market Research Reports & Industry Analysis
In considering the IASP definition, it is important to note that not all potentially tissue-damaging stimuli result in pain. Nociception is the activation of the primary afferent nerves with peripheral terminals that respond differently to noxious stimuli. Nociceptors function primarily to sense and transmit pain signals. Nociception may or may not be perceived as pain, depending on a complex interaction within the nociceptive pathways. If nociceptive stimuli are blocked, pain is not perceived. Finally, it is important to distinguish pain, or nociception, from suffering. Suffering is the state of severe distress associated with events that threaten the intactness of the person. Suffering is an emotion. Pain and suffering are not the same phenomenon.
The person who complained of pain in the heart because of the death of a loved one is suffering rather than experiencing pain as it is defined by the IASP. It is clear that three conditions could exist: 1) suffering occurs in the presence of pain,2) suffering occurs when pain is not present, and 3) pain occurs when suffering is not present. For example, the woman awaiting breast biopsy may suffer because of anticipated loss of her breast. After the biopsy, she may have pain without suffering if the biopsy is negative or pain with suffering if the biopsy is positive for malignancy. Interventions aimed at relieving pain and suffering may have some commonalities, but clearly some interventions for suffering will be inadequate for pain just as some interventions for pain are inadequate for suffering.
Pain Industry Research & Market Reports
-
Ablation Technology Market Assessment, By Product [Radiofrequency Ablators, Ultrasound Ablators, Laser/Light Ablators, Electrical Ablators, Cryoablation Devices, Microwave Ablators, Hydrothermal/Hydromechanical Ablators, Consumables], By Application [Cardiovascular Disease Treatment, Cancer Treatment, Ophthalmological Treatment, Pain Management, Urological Treatment, Orthopedic Treatment, Cosmetic/Aesthetic Surgery, Others], By End-user [Hospitals, Surgical Centers, and Ablation Centers, Ambulatory Surgery Centers, Aesthetics and Dermatology Clinics, Others], By Region, Opportunities and Forecast, 2018-2032F
... for minimally invasive procedures, rising regulatory approvals for advanced devices, and a surge in strategic partnerships between medical device companies and healthcare providers. Additionally, the growing prevalence of chronic diseases like cancer and cardiovascular conditions ... Read More
-
2025 Global: Hip Osteoarthritis Pain Drug Market - Innovative Markets Forecast (2031) report
... accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only ... Read More
-
Global Cannabidiol (CBD) Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Pain Management Devices And Therapies Global Market Report 2025
... management devices and therapies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Global Pain Management Drugs Market - 2025-2033
... drugs, also called analgesics, are medications aimed at alleviating pain. These are classified into several categories, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, corticosteroids, muscle relaxants, anticonvulsants, etc. NSAIDs are commonly used for mild to moderate ... Read More
-
In-vivo CRO Market Report by Type (Rodent, Non-Rodent), GLP Type (Non-GLP, GLP Toxicology), Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, and Others), and Region 2025-2033
... The growing prevalence of chronic diseases worldwide and the increasing R&D expenditure by pharmaceutical companies are propelling the market growth. In-vivo contract research organizations (CROs) are institutions that conduct extensive biopharmaceutical research on a contractual ... Read More
-
Nanocapsules
... 6.3% over the analysis period 2024-2030. Oncology, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in ... Read More
-
Chronic Spinal Cord Injury- Pipeline Insight, 2025
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Chronic Spinal ... Read More
-
Migraine Drugs
... CAGR of 16.0% over the analysis period 2024-2030. Acute Treatment, one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach US$7.2 Billion by the end of the analysis ... Read More
-
Pain Management Devices
... at a CAGR of 7.8% over the analysis period 2024-2030. Neurostimulation Devices, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$3.5 Billion by the end of ... Read More
-
Fibromyalgia Therapeutics
... CAGR of 2.9% over the analysis period 2024-2030. Antiepileptics, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$2.1 Billion by the end of the analysis period. ... Read More
-
Veterinary Pain Management
... at a CAGR of 7.9% over the analysis period 2024-2030. Drugs, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.1 Billion by the end of the ... Read More
-
Anticonvulsant Drugs Market, by Drug Class (Barbiturates, Benzodiazepines, Aromatic allylic alcohols, Carboxamides, Triazine, AMPA receptor antagonists, Carbamate, Hydantoin, Fatty Acid Derivative, GABA analogs, Valproylamides, Others (Propionates, Oxazolidinediones, etc.)), by Route of Administration (Enteral, Parenteral), by Indication (Epilepsy, Neuropathic pain, Anxiety, Fibromyalgia, Bipolar Disorder, Others (Borderline personality disorder, etc.)), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... borderline personality disorder. Anticonvulsants, including gabapentin, carbamazepine, and valproic acid, are believed to alleviate chronic pain by obstructing sodium (valproate and the gabapentanoids) or calcium (carbamazepine and Oxcarbazepine) channels at the cellular neuronal level. This ... Read More
-
Chronic Lower Back Pain Global Market Opportunities And Strategies To 2034
... back pain market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. Understand how the market ... Read More
-
Kratom Market Research Report Information by Product Type (Powdered Kratom, Kratom Extracts, Kratom Capsules & Tablets and Kratom Tinctures), by Form (Processed and Raw Leaves), by End User (Pain Management, Mood Enhancement, Energy & Focus and Relaxation & Anxiety Relief), by Distribution Channel (store-based and non-store based), and By Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Industry Forecast Till 2032
... by the conclusion of the forecast period (2023-2032), which was estimated to be USD 5,138.00 million in 2022. In the past few years, the Kratom Market has experienced a series of significant trends that are ... Read More
-
2025 Global Forecast for Hip Osteoarthritis Pain Drug Market (2026-2031 Outlook)-High Tech Outlook Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Medical Marijuana Market Size, Share, and Outlook, 2025 Report- By Product (Flower, Oil & Tinctures ), By Application (Cancer, Chronic Pain, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Post-Traumatic Stress Disorder (PTSD), Parkinson's Disease, Tourettes, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Medical Marijuana segments across 22 countries from 2021 to 2032. ... Read More
-
Medical Foods Market Size, Share, and Outlook, 2025 Report- By Route of Administration (Oral, Enteral), By Product (Powder, Pills, Liquid, Other), By Application (Chronic Kidney Disease, Minimal Hepatic Encephalopathy, Chemotherapy Induced Diarrhea, Pathogen Related Infections, Diabetic Neuropathy, ADHD, Depression, Alzheimer's Disease, Nutritional Deficiency, Orphan Diseases, Wound Healing, Chronic Diarrhea, Constipation Relief, Protein Booster, Dysphagia, Pain Management, Parkinson's Disease, Epilepsy, Severe Protein Allergy, Cancer, Cachexia, Others), By Sales Channel (Online Sales, Retail Sales, Institutional Sales), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Medical Foods segments across 22 countries from 2021 to 2032. ... Read More
-
Pharmaceutical Manufacturing Market Size, Share, and Outlook, 2025 Report- By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules)), By Drug Development (In-house, Outsource), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Route of Administration (Oral, Topical, Parenteral, Inhalations, Others), By Therapy Area (Cardiovascular Diseases, Pain, Diabetes, Cancer, Respiratory Diseases, Others), By Prescription (Prescription Medicines, Over-the-counter (OTC) Medicines), By Age group (Children & Adolescents, Adults, Geriatric), By Sales Channel (Retail, Non-retail), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Pharmaceutical Manufacturing segments across 22 countries from 2021 to 2032. ... Read More
-
Buccal Drug Delivery Systems Market Size, Share, and Outlook, 2025 Report- By Type (Sublingual Films, Buccal Tablets and Lozenges, Oral Sprays), By Application (Pain Management, Smoking Cessation, Angina Pectoris, Others), By End-User (Hospitals, Ambulatory Centers, Others), 2021-2032
... business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Buccal Drug Delivery Systems ... Read More
-
Bovine Mastitis Market, by Type (Clinical Mastitis and Sub-clinical Mastitis), by Product (Antibiotics, Vaccines, Pain Killers, and Others), by Route of Administration (Intra-mammary and Systemic), by Therapy (Lactating Period, Dry Period (Antibiotics, and Teat Sealants)), by End User (Veterinary Centers, Hospital, Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... prevalent in dairy cows globally. It's a condition known for causing damage on the dairy industry's profit margin. Mastitis is caused by a huge number of different microorganism species. Viruses, mycoplasmas, fungi, and bacteria are ... Read More
-
Vulvodynia Treatment Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Global Neurotech Devices Market, By Product Type (Neurostimulation, Deep brain stimulator, Gastric electric stimulator, Spinal cord stimulator, Sacral nerve stimulator, Vagus nerve stimulator, Transcutaneous electrical nerve stimulation, Other neurostimulations, Neuroprostheses, Neurosensing, Neurorehabilitation devices), By Conditions (Pain management, Cognitive disorders, Epilepsy, Urinary and fecal incontinence, Hearing conditions, Parkinsons disease, Depression, Sleep disorders, Essential tremor, Other conditions), By End User (Hospitals, Ambulatory surgical centers, Homecare facilities, Other end users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... damaged pathways in the brain or spinal cord. Conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and chronic pain that have proved difficult to treat with conventional therapies may potentially benefit from targeted neuromodulation approaches. ... Read More
-
NEUROTECHNOLOGY MARKET - GROWTH, TRENDS, AND FORECASTS (2025 - 2030)
... are driving the growth of the neuroelectronics market include the increasing prevalence of neurological disorders, rapid advancements in neuroscience and technology, and the rising demand for improved treatment options. The rising incidence of neurological disorders, ... Read More
-
Elastomeric Infusion Pumps Market, by Product Type (Variable Rate Elastomeric Pumps, Continuous Rate Elastomeric Pumps), by Treatment (Pain Management, Antibiotic/Antiviral, Chemotherapy, Others), by End User (Ambulatory Surgical Centers, Clinics, Home Care Settings, Hospitals, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... medical devices used for drug infusion. The process of infusion is carried out with the help of consistent pressure created in the elastomeric layer present in the pump which is controlled with the help of ... Read More
Research Assistance
